5AM Ventures Sells $239K of Skye Bioscience, Exits Two Funds
SKYE sits 16% above its 52-week low of $1.5.
Summary
5AM Ventures sold $239,555 of Skye Bioscience stock on September 22-23, exiting two of its funds entirely while retaining a larger position in Ventures VII.
Key Events · Ownership and Investor Activity · SKYE
-
5AM Ventures Sells $239K
Sold 148,079 shares at $1.61-$1.65 on September 22-23, 2026, for total proceeds of $239,555.
-
Two Funds Fully Liquidated
Ventures II and Co-Investors II reduced their Skye holdings to zero, while Ventures VII retains 981,269 shares.
-
Continuing Distribution Pattern
Follows prior sales of 300,000 shares on August 18 and 75,840 shares on August 19-20, totaling over $410K in 90-day insider selling.
-
Reverse Merger Context
Sales come after the August 14 Redx Pharma reverse merger announcement, which leaves Skye shareholders with only 5.38% of the combined company.
Analysis · SKYE · Life Sciences
5AM Ventures sold 148,079 shares for $239,555 across September 22-23, fully liquidating its Ventures II and Co-Investors II positions. This continues a pattern of insider selling that began in August after the Redx reverse merger announcement. The sale represents a meaningful portion of the company's tiny float and adds to the overhang on a stock already facing delisting risk and a going-concern warning.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SKYE was trading at $1.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.5M. The 52-week trading range was $1.50 to $39.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.